Friday June 2nd, 2023 7:46AM

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that's been the go-to treatment against the coronavirus.

More than 11 million prescriptions for Paxlovid have been dispensed since the Food and Drug Administration allowed emergency use in late 2021. The emergency status was based on early studies and was intended to be temporary pending follow-up research.

The FDA granted full approval for adults with COVID-19 who face high risks of severe disease, which can lead to hospitalization or death. That group typically includes older adults and those with common medical conditions like diabetes, asthma and obesity.

The decision allows Pfizer's drug to remain on the market indefinitely and to be marketed similarly to other drugs.

The pill is still available for children ages 12 to 17 under a separate emergency authorization.

The U.S. government has stockpiled millions of doses of Paxlovid and patients will continue to receive it at no charge, the FDA said in a statement. More than 14,000 new COVID-19 cases were reported each week last month, although most U.S. cases are no longer reported to health authorities.

Paxlovid is the fourth drug for COVID-19 to receive full FDA approval and the first one that is a pill. The previously approved therapies are IV or injectable drugs, typically given at clinics or hospitals.

Pfizer originally studied Paxlovid in the highest-risk COVID-19 patients: unvaccinated adults with other health problems and no evidence of prior coronavirus infection. In that group, the FDA said the drug lowered the risk of hospitalization or death by 86% when given shortly after symptoms emerged.

But that doesn’t reflect the U.S. population today, where more than 95% of people have protection from at least one vaccine dose, a prior infection or both.

In more recent studies of people who have had COVID-19, Paxlovid still significantly decreased the chance of hospitalization or death by more than 85%.

As Paxlovid became widely used in 2021, doctors and patients reported cases of COVID-19 symptoms returning several days after treatment with the drug. But the FDA said Thursday “there is not a clear association,” between Pfizer’s drug and rebound cases.

That conclusion was backed by an independent panel of FDA advisers, who voted to recommend the drug's full approval at a meeting earlier this year.


The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.

  • Associated Categories: Associated Press (AP), AP National News, AP Online National News, AP Health, AP Business
© Copyright 2023 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
COVID pill Paxlovid gets full FDA approval after more than a year of emergency use
U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid
1:11PM ( 3 minutes ago )
Sports no sure respite from politics when title-winning athletes visit the White House
Politics and sports go together like baseball and apple pie
12:59PM ( 15 minutes ago )
Dudamel in surprise move resigns from Paris Opéra 2 years into 6-year contract
Gustavo Dudamel surprisingly announced his resignation as music director of the Paris Opéra, two seasons into a six-year contract scheduled to run through the 2026-27 season
12:44PM ( 29 minutes ago )
Associated Press (AP)
Twitter's launch of DeSantis' presidential bid underscores platform's rightward shift under Musk
While shaky and skewered by critics, Twitter’s forum for Florida Gov. Ron DeSantis to announce his presidential run nevertheless underscored the platform’s unmistakable shift to the right under new owner Elon Musk
11:46AM ( 1 hour ago )
Debt default 'X-date' calculations aim to figure out when the US may run short of cash
For all the concern over when the government might run out of money to cover all its bills, it turns out that no one can be absolutely sure exactly when the country faces a potential default — the dreaded “X-date.”
11:42AM ( 1 hour ago )
Weeks before EU and Latin American joint summit, trade deal remains elusive
The European Union and the Mercosur group of Latin American nations are still struggling to bridge the last difference before they can reach final agreement on a long-delayed trade deal
11:28AM ( 1 hour ago )
AP Business
Sports no sure respite from politics when title-winning athletes visit the White House
Politics and sports go together like baseball and apple pie
12:59PM ( 15 minutes ago )
US senator hopes Serbia adopts Russia sanctions as Serb spy chief travels to Moscow
A U.S. senator says he hopes Serbia adopts Western sanctions against Russia over the invasion of Ukraine, telling the Balkan country that “there is no future” in an alliance with Moscow
12:36PM ( 37 minutes ago )
Tina Turner created a career on her terms, not defined by her trauma
Tina Turner escaped a violent marriage to a controlling musical partner and empowered herself to emerge through a musical renaissance
12:31PM ( 42 minutes ago )
Cannes turns up the glamour as Queen Latifah hosts the amfAR gala. Watch the red carpet
The attention at the Cannes Film Festival turns Thursday to the glitzy amfAR gala to raise money for AIDS research
12:31PM ( 42 minutes ago )
Threat of US credit downgrade looms over debt ceiling talks
With one of three major rating agencies warning that America’s AAA credit is at risk, the stakes are growing in the standoff in Washington over raising the nation’s debt limit
12:25PM ( 48 minutes ago )